Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy

PHASE2CompletedINTERVENTIONAL
Enrollment

500

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Venous ThromboembolismHaemorrhage
Interventions
DRUG

Rivaroxaban

10 mg os once daily for 1 week

DRUG

placebo

10 mg os once daily for 1 week

Trial Locations (9)

20089

Thrombosis Center & Knee Arthroscopy and Sports Medicine Center, Humanitas Clinical Insitute, Rozzano

42100

Unit of Angiology, Department of Internal Medicine, Azienda Ospedaliera - IRCCS, Reggio Emilia

Unknown

"Department of Orthopaedics and Traumatology, University Hospital Galliera of Genova", Genova

Department of Internal Medicine, University Hospital of Napoli, Napoli

Department of Orthopaedics and Traumatology, University Hospital of Pavia, Pavia

Department of Internal Medicine, Hospital of Piacenza, Piacenza

"Department of Orthopedics and Surgery of the Hand, Catholic University Sacro Cuore", Rome

Unit of Angiology, Hospital of Venice, Venice

06123

Section of Internal and Cardiovascular Medicine, Department of Internal Medicine, University of Perugia, Perugia

All Listed Sponsors
lead

University of Padova

OTHER

NCT01629381 - Efficacy of RIvaroxaban for Prevention of Venous Thromboembolism After Knee Arthroscopy | Biotech Hunter | Biotech Hunter